Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agents

This publication has 8 references indexed in Scilit:

• Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine
  British Journal of Cancer, 1988
• The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin—Implications for theraphy
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow
  British Journal of Cancer, 1985
• Abnormal Response of Tumor Vasculature to Vasoactive Drugs23
  JNCI Journal of the National Cancer Institute, 1984
• Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs
  European Journal of Cancer and Clinical Oncology, 1982
• An in Vitro Assay to Measure the Viability of KHT Tumor Cells Not Previously Exposed to Culture Conditions
  Radiation Research, 1974
• Blood flow and oxygenation of tumors in mice.II. Effects of vasodilator drugs
  Cancer, 1967